Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...

The implementation of the revised Schedule M marks a critical step towards enhancing the quality and safety of pharmaceutical ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

SEOUL, South Korea and RIYADH, Saudi Arabia /PRNewswire/ -- Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-Jae Lee) ...

Currrax Pharmaceuticals over-performed its 2024 revenue goal and has exceeded 50% year-over-year revenue growth for its ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

The three-day-long 16th Asia Pharma Expo'-2025 kicked off at the Bangladesh-China Friendship Exhibition Center in Purbachal New Town today (12 February). The Bangladesh Association of Pharmaceutical ...

Venkatasubramanian earned his BS in chemical engineering from the University of Madras, an MS in physics from Vanderbilt ...

West Pharmaceutical Services eyes fourth-quarter growth amid pharma stabilization, biologics rebound & contract manufacturing gains. Can WST sustain its momentum?

Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.